journal article·2014-05Open access

In vitro and in vivo experiments with iron oxide nanoparticles functionalized with DEXTRAN or polyethylene glycol for medical applications: Magnetic targeting

M. L. Mojica Pisciotti, E. Lima, M. Vasquez Mansilla, V. E. Tognoli, H. E. Troiani, A. A. Pasa, T. B. Creczynski‐Pasa, A. H. Silva, P. Gurman, L. Colombo, G. F. Goya, A. Lamagna, R. D. Zysler

Abstract

ABSTRACT In this research work, DEXTRAN‐ and polyethylene glycol (PEG)‐coated iron‐oxide superparamagnetic nanoparticles were synthetized and their cytotoxicity and biodistribution assessed. Well‐crystalline hydrophobic Fe3O4 SPIONs were formed by a thermal decomposition process with d = 18 nm and σ = 2 nm; finally, the character of SPIONs was changed to hydrophilic by a post‐synthesis procedure with the functionalization of the SPIONs with PEG or DEXTRAN. The nanoparticles present high saturation magnetization and superparamagnetic behavior at room temperature, and the hydrodynamic diameters of DEXTRAN‐ and PEG‐coated SPIONs were measured as 170 and 120 nm, respectively. PEG‐ and DEXTRAN‐coated SPIONs have a Specific Power Absorption SPA of 320 and 400 W/g, respectively, in an ac magnetic field with amplitude of 13 kA/m and frequency of 256 kHz. In vitro studies using VERO and MDCK cell lineages were performed to study the cytotoxicity and cell uptake of the SPIONs. For both cell lineages, PEG‐ and DEXTRAN‐coated nanoparticles presented high cell viability for concentrations as high as 200 μg/mL. In vivo studies were conducted using BALB/c mice inoculating the SPIONs intravenously and exposing them to the presence of an external magnet located over the tumour. It was observed that the amount of PEG‐coated SPIONs in the tumor increased by up to 160% when using the external permanent magnetic as opposed to those animals that were not exposed to the external magnetic field. © 2014 Wiley Periodicals, Inc. J Biomed Mater Res Part B: Appl Biomater, 102B: 860–868, 2014.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Nanoparticle-Based Drug Delivery · Characterization and Applications of Magnetic Nanoparticles · Iron oxide chemistry and applications

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Div. Resonancias Magnéticas, Centro Atómico Bariloche/CONICET S. C. Bariloche 8400 Argentina

Div. Física de Metales, Centro Atómico Bariloche/CONICET S. C. Bariloche 8400 Argentina

Depto. de Física, Universidade Federal de Santa Catarina Florianópolis 88040‐900 Brazil

Depto. de Ciências Farmacêuticas, Universidade Federal de Santa Catarina Florianópolis 88040‐900 Brazil

Depto. de Micro y Nanotecnologia, Centro Atómico Constituyentes San Martin 1650 Argentina

Instituto de Oncología A.H. Roffo, UBA/CONICET/CAECIHS (UAI) Av. San Martín 5481, (1417) CABA Argentina

Instituto de Nanociencia de Aragón, Universidad de Zaragoza Zaragoza 50018 Spain

References (49)

Show source-provided references
1. Bruton LL · 2011
2. Clinical Experiences with Magnetic Drug Targeting: A Phase I Study with 4′‐Epidoxorubicin in 14 Patients with Advanced Solid Tumors
3. 10.1007/s10565-011-9191-910.1007/s10565-011-9191-9 ↗
4. 10.1049/ip-nbt:2005501810.1049/ip-nbt:20055018 ↗
5. 10.1016/j.addr.2008.03.01410.1016/j.addr.2008.03.014 ↗
6. 10.1016/S0304-8853(98)00578-210.1016/S0304-8853(98)00578-2 ↗
7. 10.1117/12.87641410.1117/12.876414 ↗
8. 10.1088/0957-4484/22/34/34510110.1088/0957-4484/22/34/345101 ↗
9. 10.2147/IJN.S1665310.2147/IJN.S16653 ↗
10. 10.1007/s00259-006-0091-910.1007/s00259-006-0091-9 ↗
11. 10.1016/j.ab.2004.03.04910.1016/j.ab.2004.03.049 ↗
12. 10.2310/7290.2007.0001410.2310/7290.2007.00014 ↗
13. 10.1021/mp900161h10.1021/mp900161h ↗
14. 10.1016/j.neuroimage.2004.09.01410.1016/j.neuroimage.2004.09.014 ↗
15. 10.1002/mrm.1006610.1002/mrm.10066 ↗
16. 10.2147/IJN.S586410.2147/IJN.S5864 ↗
17. 10.1166/jbn.2013.146710.1166/jbn.2013.1467 ↗
18. Subtle cytotoxicity and genotoxicity differences in superparamagnetic iron oxide nanoparticles coated with various functional groups
19. Magnetic brain tumor targeting and biodistribution of long‐circulating PEG‐modified, cross‐linked starch‐coated iron oxide nanoparticles10.1016/j.biomaterials.2011.05.024 ↗
20. Toxic effects of iron oxide nanoparticles on human umbilical vein endothelial cells
21. 10.1021/nn200365a10.1021/nn200365a ↗
22. 10.1016/j.biomaterials.2009.08.04010.1016/j.biomaterials.2009.08.040 ↗
23. 10.1088/0957-4484/18/3/03560310.1088/0957-4484/18/3/035603 ↗
24. 10.1021/ja026501x10.1021/ja026501x ↗
25. 10.1021/ja038085210.1021/ja0380852 ↗
26. 10.1088/0957-4484/16/9/00910.1088/0957-4484/16/9/009 ↗
27. 10.1016/j.synthmet.2010.02.03110.1016/j.synthmet.2010.02.031 ↗
28. 10.1021/la063619910.1021/la0636199 ↗
29. 10.1016/0022-1759(83)90303-410.1016/0022-1759(83)90303-4 ↗
30. 10.1016/j.toxicon.2006.06.00410.1016/j.toxicon.2006.06.004 ↗
31. 10.1016/j.trac.2012.11.00410.1016/j.trac.2012.11.004 ↗
32. 10.1007/s00284-009-9490-z10.1007/s00284-009-9490-z ↗
33. 10.1063/1.351458510.1063/1.3514585 ↗
34. Smit J · 1959
35. 10.1016/j.colsurfb.2011.08.01310.1016/j.colsurfb.2011.08.013 ↗
36. 10.1021/ar200013810.1021/ar2000138 ↗
37. 10.1007/s10439-005-9002-710.1007/s10439-005-9002-7 ↗
38. Magnetic properties of encapsulated magnetite in PLGA nanospheres10.12693/APhysPolA.113.595 ↗
39. Infrared study of biocompatible magnetic nanoparticles
40. 10.1007/s00449-009-0354-510.1007/s00449-009-0354-5 ↗
41. 10.1016/j.addr.2011.09.00110.1016/j.addr.2011.09.001 ↗
42. 10.1088/0957-4484/22/20/20510110.1088/0957-4484/22/20/205101 ↗
43. Magnetically Directed Targeting Aggregation of Radiolabelled Ferrite Nanoparticles
44. 10.1063/1.219147110.1063/1.2191471 ↗
45. 10.1088/0957-4484/21/7/07510210.1088/0957-4484/21/7/075102 ↗
46. 10.1097/00004424-200210000-0000810.1097/00004424-200210000-00008 ↗
47. 10.1007/s11060-006-9195-010.1007/s11060-006-9195-0 ↗
48. 10.1007/s00249-007-0197-410.1007/s00249-007-0197-4 ↗
49. 10.1016/j.jmmm.2005.01.04710.1016/j.jmmm.2005.01.047 ↗